Skip to content

Clinical trials

Phase 3 Pancreatic Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 3 Country / region: United Kingdom Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20021
20051
20062
20071
20112
20143
20151
20171
20221
20241
20251
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting6
Terminated2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Revolution Medicines, Inc.3
Eli Lilly and Company2
Incyte Corporation2
Royal Liverpool University Hospital2
Arcus Biosciences, Inc.1
Astellas Pharma Global Development, Inc.1
AstraZeneca1
Cancer Research UK1
Celgene1
Health Clinics Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms24
Neoplasm Metastasis4
Neoplasms4
Endocrine Gland Neoplasms2
Adenocarcinoma1
Brain Neoplasms1
Breast Neoplasms1
Carcinoma, Islet Cell1
Colonic Neoplasms1
Digestive System Diseases1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.